Clinical Trial Update: Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating adoptive transfer of CD8+ T cells targeting melanoma antigens in metastatic melanoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Nantes University Hospital | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: COMPLETED